[{"id":"93335065-f675-4fa3-860c-4d655b29773a","acronym":"","url":"https://clinicaltrials.gov/study/NCT04166838","created_at":"2021-01-18T20:19:58.278Z","updated_at":"2024-07-02T16:36:53.599Z","phase":"Phase 1","brief_title":"The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)","source_id_and_acronym":"NCT04166838","lead_sponsor":"Shanghai Longyao Biotechnology Inc., Ltd.","biomarkers":" CD19","pipe":" | ","alterations":" CD19 expression","tags":["CD19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 UCART cells"],"overall_status":"Unknown status","enrollment":" Enrollment 20","initiation":"Initiation: 11/08/2019","start_date":" 11/08/2019","primary_txt":" Primary completion: 11/08/2019","primary_completion_date":" 11/08/2019","study_txt":" Completion: 11/08/2019","study_completion_date":" 11/08/2019","last_update_posted":"2019-11-18"}]